• Cell Therapeutics, Inc. (CTIC) Pays $30 Million in Cash and Stock for S*Bio's Selective JAK2 Inhibitor More...

• Cannabis Science Inc. in Final Negotiations to Purchase 50% of what will be a 10,000 Square Foot Cancer Centre in Arizona With Over 500 Existing Medical Cannabis Patients More...

• Baxter International, Inc. (BAX)'s $1 Billion Plant to Bring 1,500 High-paying Jobs to Metro Atlanta More...

• Janssen Pharmaceutica N.V. Creates New Division to Launch TMC435 and Help Conquer Hepatitis C in EMEA More...

• Alder Biopharmaceuticals Inc. Snags $38 Million to Charge Ahead With Antibody Drugs More...

• Amgen (AMGN) to Assume Some Enbrel Sales Work From Pfizer Inc. (PFE); Declined to Say How Many Employees are Affected - Amgen to Hire the Second Half of 2012 More...

• Iris Pharma and RxGen, Inc. Announce Strategic Alliance More...

• Adimab LLC. Announces New Antibody Discovery Program with Gilead Sciences, Inc. (GILD) and Initiates First Bispecific Antibody Collaboration More...

• Xencor Receives Milestone Payment from CSL Limited (CMXHF.PK) Under Antibody Optimization Collaboration More...

• Sanofi (France) (SAN.PA) and The Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's Disease More...

• Sorbent Therapeutics, Inc. Announces Additions to Leadership Team More...

• Rockwell Medical Technologies (RMTI) Appoints Raymond Pratt, M.D. FACP as Chief Medical Officer More...

• EnVivo Pharmaceuticals, Inc. Names Christopher L. Burnley Chief Business Officer More...

• RetroSense Therapeutics Welcomes Dr. Peter Francis as Clinical Director More...

• Kal Sundaram Appointed to Taro Pharmaceutical Industries Ltd. (TARO)'s Board of Directors as Chairman More...

• Aceto Corporation Schedules Fiscal 2012 Third Quarter Financial Results News Release and Conference Call More...

• Baxter International, Inc. (BAX) Exceeds Revenue and EPS Guidance with Solid First Quarter Financial Results More...

• Cubist Pharmaceuticals, Inc. (CBST) Reports First Quarter 2012 Financial Results More...

• Dr. Reddy's Laboratories, Inc. (RDY)'s to Release Q4 & Full Year FY12 Results on May 11, 2012 More...

• ImmunoGen, Inc. (IMGN) Announces Conference Call to Discuss its Third Quarter Fiscal Year 2012 Financial Results More...

• Watson Pharmaceuticals, Inc. (WPI) Confirms Glumetza® Patent Challenge More...

• Merck & Co., Inc. (MRK) Wins Another FOSAMAX® (alendronate sodium) State Court Trial More...

• The Dow Chemical Company (DOW) to Build New Ethylene Production Plant at Dow Texas Operations More...

• Gilead Sciences, Inc. (GILD)-Bristol-Myers Squibb Company (BMY)'s Hep C Drug Cured 88% Post-Therapy More...

• Boehringer Ingelheim Corporation Hepatitis C Drugs Cured 82% in Phase II Trial More...

• Abbott Laboratories (ABT) Reports Two Hepatitis C Relapses in "Pilot" Trial More...

• Medivir AB (MVIRb.F) Hep C Drug Cures 80% of Patients Post-Treatment More...

• Neurology Publishes Results From Pivotal Study of Eisai Inc. (ESALF.PK)'s Perampanel More...

• SCOLR Pharma, Inc. (DDD)'s Partner Announces Successful Results in Pivotal Bioequivalence Trial and Plans for a pre-NDA meeting More...

• Joint Failures Potentially Linked to Oral Bacteria, Case Western Research University School of Dental Medicine Study More...

• How Selective Hearing Works in the Brain: "Cocktail Party Effect" Explained,University of California, San Francisco (UCSF) Study More...

• Any Kind of Physical Activity Lowers Alzheimer's Risk, Rush University Medical Center Study More...

• When Art Touches a Nerve, Brain Lights Up, New York University Study More...

• New Data Released At ISHLT Meeting May Impact Treatment for Patients With Pulmonary Arterial Hypertension More...